-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2023 to Q3 2025.
- Neuphoria Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$9,906,504.000, a 1131% decline year-over-year.
- Neuphoria Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$9,501,717.000, a 12.2% increase year-over-year.
- Neuphoria Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2025 was -$400,000.000, a 97.4% increase from 2024.
- Neuphoria Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$15,492,166.000, a 27.5% increase from 2023.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)